2017 Form 10-K Financial Statement

#000143774918005827 Filed on March 29, 2018

View on sec.gov

Income Statement

Concept 2017 2016 Q4 2016
Revenue $6.862M $1.410M $6.102M
YoY Change 12.45% -5.37% -10.58%
Cost Of Revenue $2.824M $510.0K $2.183M
YoY Change 29.36% -7.27% -13.72%
Gross Profit $4.038M $900.0K $3.919M
YoY Change 3.04% -4.26% -8.73%
Gross Profit Margin 58.85% 63.83% 64.22%
Selling, General & Admin $2.625M $610.0K $2.827M
YoY Change -7.15% -17.57% -9.42%
% of Gross Profit 65.01% 67.78% 72.14%
Research & Development $2.162M $590.0K $2.499M
YoY Change -13.49% -11.94% 7.95%
% of Gross Profit 53.54% 65.56% 63.77%
Depreciation & Amortization $206.0K $70.00K $291.0K
YoY Change -29.21% -12.5% -2.68%
% of Gross Profit 5.1% 7.78% 7.43%
Operating Expenses $4.787M $1.200M $5.326M
YoY Change -10.12% -14.89% -2.02%
Operating Profit -$749.0K -$300.0K -$1.407M
YoY Change -46.77% -36.17% 23.2%
Interest Expense -$209.0K -$40.00K -$145.0K
YoY Change 44.14% 33.33% 35.51%
% of Operating Profit
Other Income/Expense, Net $928.0K
YoY Change
Pretax Income -$30.00K -$340.0K -$1.552M
YoY Change -98.07% -32.0% 24.26%
Income Tax
% Of Pretax Income
Net Earnings -$30.00K -$340.0K -$1.552M
YoY Change -98.07% -32.0% 24.26%
Net Earnings / Revenue -0.44% -24.11% -25.43%
Basic Earnings Per Share -$0.01 -$0.13
Diluted Earnings Per Share -$0.01 -$26.67K -$0.13
COMMON SHARES
Basic Shares Outstanding 12.84M 12.74M
Diluted Shares Outstanding 12.84M 12.74M

Balance Sheet

Concept 2017 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $100.0K $100.0K
YoY Change 100.0% 0.0% 0.0%
Cash & Equivalents $200.0K $64.00K $100.0K
Short-Term Investments
Other Short-Term Assets $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Inventory $0.00 $45.00K $0.00
Prepaid Expenses $75.00K
Receivables $1.000M $745.0K $700.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.300M $929.0K $900.0K
YoY Change 44.44% 16.71% 12.5%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $308.0K $300.0K
YoY Change -66.67% -36.63% -40.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $40.00K $0.00
YoY Change -6.98%
Total Long-Term Assets $200.0K $348.0K $400.0K
YoY Change -50.0% -34.22% -20.0%
TOTAL ASSETS
Total Short-Term Assets $1.300M $929.0K $900.0K
Total Long-Term Assets $200.0K $348.0K $400.0K
Total Assets $1.500M $1.277M $1.300M
YoY Change 15.38% -3.62% 0.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $205.0K $200.0K
YoY Change 0.0% -6.82% 0.0%
Accrued Expenses $1.000M $691.0K $700.0K
YoY Change 42.86% 11.45% 16.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $100.0K $100.0K
YoY Change -100.0% -50.0% -50.0%
Total Short-Term Liabilities $2.100M $1.733M $1.700M
YoY Change 23.53% 9.48% 6.25%
LONG-TERM LIABILITIES
Long-Term Debt $2.900M $2.900M $2.900M
YoY Change 0.0% 70.59% 70.59%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.900M $2.900M $2.900M
YoY Change 0.0% 70.59% 70.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.100M $1.733M $1.700M
Total Long-Term Liabilities $2.900M $2.900M $2.900M
Total Liabilities $5.000M $4.700M $4.700M
YoY Change 6.38% 42.42% 42.42%
SHAREHOLDERS EQUITY
Retained Earnings -$61.50M
YoY Change 2.59%
Common Stock $128.0K
YoY Change 1.59%
Preferred Stock
YoY Change
Treasury Stock (at cost) $362.0K
YoY Change 0.0%
Treasury Stock Shares $10.00K
Shareholders Equity -$3.500M -$3.402M -$3.400M
YoY Change
Total Liabilities & Shareholders Equity $1.500M $1.277M $1.300M
YoY Change 15.38% -3.62% 0.0%

Cashflow Statement

Concept 2017 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$30.00K -$340.0K -$1.552M
YoY Change -98.07% -32.0% 24.26%
Depreciation, Depletion And Amortization $206.0K $70.00K $291.0K
YoY Change -29.21% -12.5% -2.68%
Cash From Operating Activities $272.0K -$630.0K -$1.244M
YoY Change -121.86% -31.52% 94.38%
INVESTING ACTIVITIES
Capital Expenditures $20.00K -$10.00K $47.00K
YoY Change -57.45% 0.0% -61.16%
Acquisitions
YoY Change
Other Investing Activities $60.00K
YoY Change
Cash From Investing Activities $36.00K -$10.00K -$47.00K
YoY Change -176.6% 0.0% -60.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -148.0K 490.0K 1.253M
YoY Change -111.81% -1080.0% -935.33%
NET CHANGE
Cash From Operating Activities 272.0K -630.0K -1.244M
Cash From Investing Activities 36.00K -10.00K -47.00K
Cash From Financing Activities -148.0K 490.0K 1.253M
Net Change In Cash 160.0K -150.0K -38.00K
YoY Change -521.05% -84.69% -95.82%
FREE CASH FLOW
Cash From Operating Activities $272.0K -$630.0K -$1.244M
Capital Expenditures $20.00K -$10.00K $47.00K
Free Cash Flow $252.0K -$620.0K -$1.291M
YoY Change -119.52% -31.87% 69.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1123000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y273D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y3D
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1870000
CY2016 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1355000
CY2017 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
56000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017Q4 intz Capital Leases Future Minimum Payments Due In Four Years And Thereafter
CapitalLeasesFutureMinimumPaymentsDueInFourYearsAndThereafter
CY2017Q4 intz Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.3
CY2017 intz Defined Contribution Plan Minimum Age Required For Contribution Of Additional Amount Of Salary Per Year
DefinedContributionPlanMinimumAgeRequiredForContributionOfAdditionalAmountOfSalaryPerYear
P50Y
CY2017 intz Effective Income Tax Rate Reconciliation Remeasurement Of Deferred Taxes
EffectiveIncomeTaxRateReconciliationRemeasurementOfDeferredTaxes
11476000
CY2016 intz Effective Income Tax Rate Reconciliation Remeasurement Of Deferred Taxes
EffectiveIncomeTaxRateReconciliationRemeasurementOfDeferredTaxes
CY2017 intz Number Of Major United States Financial Institutions
NumberOfMajorUnitedStatesFinancialInstitutions
2
CY2017 intz Number Of Operating Leases
NumberOfOperatingLeases
2
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
139000
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
17000
CY2017Q4 intz Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2
CY2017Q4 intz Operating Leases Future Minimum Payments Due In Three Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInThreeYearsAndThereafter
104000
CY2017 intz Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
33000
CY2016 intz Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
20000
CY2017 intz Period Of Payment Terms Offered To Customers Distributions And Resellers Domestically
PeriodOfPaymentTermsOfferedToCustomersDistributionsAndResellersDomestically
P30D
CY2017 intz Period Of Payment Terms Offered To Customers Distributors And Resllers Internationally
PeriodOfPaymentTermsOfferedToCustomersDistributorsAndResllersInternationally
P45D
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period1
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod1
P1Y
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period2
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod2
P3Y
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period3
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod3
P5Y
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
24000
CY2016 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
69000
CY2017 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
CY2016 intz Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
CY2017 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Expiration Term For Options Granted To Holders Of More Than Specified Percentage Of Voting Stock
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationTermForOptionsGrantedToHoldersOfMoreThanSpecifiedPercentageOfVotingStock
P5Y
CY2017 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
0.42
CY2016 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
0.36
CY2017 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
CY2016 intz Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
194000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
205000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
962000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
745000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
988000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
691000
CY2017Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
139000
CY2016Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
13000
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
131000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
134000
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
284000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
279000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1695000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1491000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-107000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-107000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56518000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56595000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2941861
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3509241
CY2017Q4 us-gaap Assets
Assets
1452000
CY2016Q4 us-gaap Assets
Assets
1277000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
1290000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
929000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
66000
CY2017Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
62000
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
44000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
61000
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
61000
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
45000
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
CY2017Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
17000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
160000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-38000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3319943
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12808000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12758000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12798000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12748000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
128000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
128000
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Risk Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Financial instruments, which potentially subject us <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major U.S. financial institutions. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that we are subject to any unusual financial risk with our banking arrangements. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any significant losses on our cash and cash equivalents.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We sell our products to customers in diversified industries worldwide and periodically have rec<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">eivables from customers, primarily in North America, Europe and Asia. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company&#x2019;s operating results. We perform ongoing credit evaluations of our customers&#x2019; financial condition and generally require <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2824000
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2183000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
406000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
395000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21654000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33132000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21175000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32644000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
374000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
374000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
94000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
124000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
25000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
38000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21654000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33132000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
14000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
48000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
30000
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32000
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.0025
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
206000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
291000
CY2017Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
447000
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
303000
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
139000
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
139000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y40D
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
12000
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
43000
CY2017 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
56000
CY2016 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1094000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1190000
CY2017 us-gaap Gross Profit
GrossProfit
4038000
CY2016 us-gaap Gross Profit
GrossProfit
3919000
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1552000
CY2017Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2016Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-11478000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
890000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-345000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-528000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
11000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
28000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-43000
CY2017 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
CY2016 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
38000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-40000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
291000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
60000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
217000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
165000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-209000
CY2016 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-145000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
6000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
14000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
348000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
184000
CY2017Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1000
CY2017Q4 us-gaap Inventory Net
InventoryNet
15000
CY2016Q4 us-gaap Inventory Net
InventoryNet
45000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47000
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
139000
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
139000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
89000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
75000
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
CY2016 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
364000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
272000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1244000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-30000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1733000
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1721000
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1708000
CY2017 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Description of Business</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We develop, market, and support a family of entity identification, data mining, regulated in<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">formation compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion&#x2019;s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We market and distr<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">ibute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">References to the &#x201c;<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;, &#x201c;Intrusion&#x201d; or &#x201c;Intrusion&nbsp;Inc.&#x201d; refer to Intrusion&nbsp;Inc. and its subsidiaries. Compliance Commander&#x2122; and TraceCop&#x2122; are registered trademarks of Intrusion Inc.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>we had cash and cash equivalents of approximatel<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">y <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$224,000,</div> up from approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$64,000</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>We generated a net loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$30,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>compared to net loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,552,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>The net loss in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> included other income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">928,000,</div> of which</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$872,000</div> came from the sale of certain unused IP addresses and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$56,000</div> from the sale of an investment. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2018, </div>in addition to cash and cash equivalents, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$835,000</div> of funding is available from a promissory note to borrow up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.7</div> million from G. Ward Paxton, the Company&#x2019;s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019. </div>We expect to fund our operations through anticipated Company profits, borrowings from the Company&#x2019;s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be on terms which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> favorable to us and, in the case of equity financings, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in dilution to our stockholders. If our operations do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate positive cash flow in the upcoming year, or if we are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be unable to implement our business plan, fund our liquidity needs or even continue our operations.</div></div></div>
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1819000
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
55000
CY2016Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
48000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1452000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1277000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2079000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-148000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1253000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
36000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-1552000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1691000
CY2017Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2865000
CY2016Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2885000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-749000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-1407000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1041000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
321000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
311000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
305000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
350000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
415000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
86000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
81000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40000
CY2017 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
928000
CY2016 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1799000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124000
CY2017Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
56000
CY2016 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
308000
CY2017 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
CY2016 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
364000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
139000
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
202000
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1890000
CY2016 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2162000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2499000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61529000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61499000
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6862000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6102000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.1024
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7546
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0164
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1662000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2079000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.68
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.59
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
482000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
259000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1531000
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1637000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
18000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
96000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
18000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.26
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.28
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2254000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2598000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1746000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.63
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.68
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1178000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1738000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.68
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.22
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.73
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.55
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.35
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.80
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1662000
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1746000
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.68
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.68
CY2017 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y10D
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
136000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-3509000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-3402000
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
362000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amount<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">s of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12836000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12737000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12836000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12737000

Files In Submission

Name View Source Status
0001437749-18-005827-index-headers.html Edgar Link pending
0001437749-18-005827-index.html Edgar Link pending
0001437749-18-005827.txt Edgar Link pending
0001437749-18-005827-xbrl.zip Edgar Link pending
ex_108724.htm Edgar Link pending
ex_108725.htm Edgar Link pending
ex_108726.htm Edgar Link pending
ex_108727.htm Edgar Link pending
ex_108728.htm Edgar Link pending
ex_108729.htm Edgar Link pending
ex_109292.htm Edgar Link pending
ex_109323.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
intz-20171231.xml Edgar Link completed
intz-20171231.xsd Edgar Link pending
intz-20171231_cal.xml Edgar Link unprocessable
intz-20171231_def.xml Edgar Link unprocessable
intz-20171231_lab.xml Edgar Link unprocessable
intz-20171231_pre.xml Edgar Link unprocessable
intz20171231_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending